Neuro-atriomyodegenerative origin of atrial fibrillation and superimposed conventional risk factors: Continued search to configure the genuine etiology of "eternal arrhythmia"

Journal of Atrial Fibrillation

Volumn 9, Issue 4, 2016, Pages

  Stirbys, Petras ^a  

^a KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

Author keywords

Aging; Arrhythmogenic substrate; Atrial fibrillation; Autonomous nervous system; Cellular senescence; Fusion reasons; Ganglionated plexi; Involution; Neuro atriomyodegenerative origin; Pseudo toxins; Superimposed risk factors; Toxins

Indexed keywords

LIPID; PROTEIN; TOXIN;

AGE; AGING; APOPTOSIS; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; AUTONOMIC INNERVATION; BLOOD VESSEL INJURY; CARDIAC MUSCLE; CARDIOVASCULAR RISK; CELL AGING; CELL DAMAGE; CELL DEGENERATION; CHRONIC TOXICITY; DIABETES MELLITUS; EXTRACELLULAR SPACE; FIBROSING ALVEOLITIS; FIBROSIS; HEART ARRHYTHMIA; HEART ATRIUM; HEART FAILURE; HUMAN; HYPERTENSION; HYPOTHESIS; INFLAMMATION; LIPOGENESIS; MICROANGIOPATHY; MUSCLE ATROPHY; NERVE DEGENERATION; NEUROATRIOMYODEGENERATION; NONHUMAN; PATHOGENESIS; PROTEIN SYNTHESIS; REVIEW; RISK FACTOR; VALVULAR HEART DISEASE;

EID: 85017564875     PISSN: None     EISSN: 19416911     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Wilke Thomas, Groth Antje, Mueller Sabrina, Pfannkuche Matthias, Verheyen Frank, Linder Roland, Maywald Ulf, Bauersachs Rupert, Breithardt Günter. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15 (4):486-93.
2. Krijthe Bouwe P, Kunst Anton, Benjamin Emelia J, Lip Gregory Y H, Franco Oscar H, Hofman Albert, Witteman Jacqueline C M, Stricker Bruno H, Heeringa Jan. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur. Heart J. 2013;34 (35):2746-51.
3. van Marion MSc Denise M S, Lanters Md Eva A H, Wiersma MSc Marit, Allessie Md Ph DMaurits A, Brundel Ph DBianca B J J M, de Groot Md Ph DNatasja M S. Diagnosis and Therapy of Atrial Fibrillation: The Past, The Present and The Future. J Atr Fibrillation. 2015;8 (2):-.
4. Xu Guo-Jun, Gan Tian-Yi, Tang Bao-Peng, Chen Zu-Heng, Mahemuti Ailiman, Jiang Tao, Song Jian-Guo, Guo Xia, Li Yao-Dong, Miao Hai-Jun, Zhou Xian-Hui, Zhang Yu, Li Jin-Xin. Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences. Exp Ther Med. 2013;5 (3):723-729.
5. Wyse D George, Van Gelder Isabelle C, Ellinor Patrick T, Go Alan S, Kalman Jonathan M, Narayan Sanjiv M, Nattel Stanley, Schotten Ulrich, Rienstra Michiel. Lone atrial fibrillation: does it exist?. J. Am. Coll. Cardiol. 2014;63 (17):1715-23.
6. Woods Christopher E, Olgin Jeffrey. Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation. Circ. Res. 2014;114 (9):1532-46.
7. Lee Jung Myung, Lee Hancheol, Janardhan Ajit H, Park Junbeom, Joung Boyoung, Pak Hui-Nam, Lee Moon-Hyoung, Kim Sung Soon, Hwang Hye Jin. Prolonged atrial refractoriness predicts the onset of atrial fibrillation: A 12-year follow-up study. Heart Rhythm. 2016;13 (8):1575-80.
8. Nguyen Bich Lien, Fishbein Michael C, Chen Lan S, Chen Peng-Sheng, Masroor Saqib. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm. 2009;6 (4):454-60.
9. Van Gelder I C, Smit M D, Alings M, Crijns H J G M. Upstream therapy in patients with early atrial fibrillation: The relevance of the Routine versus Aggressive upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) study. Neth Heart J. 2010;18 (11):522-3.
10. Wyndham C R. Atrial fibrillation: the most common arrhythmia. Tex Heart Inst J. 2000;27 (3):257-67.
11. Y Shah, MFerrara, EHansinger, DLMusat, MWPreminger. Re-ablation procedural findings and clinical outcomes in patients with very late recurrence after initially successful ablation of atrial fibrillation (Abstr.). Heart Rhythm. 2016. 2006;0:469-0.
12. Takahashi Kenta, Miyauchi Yasushi, Hayashi Meiso, Iwasaki Yu-Ki, Yodogawa Kenji, Tsuboi Ippei, Hayashi Hiroshi, Oka Eiichiro, Ito Hagiwara Kanako, Fujimoto Yuhi, Shimizu Wataru. Mechanisms of postoperative atrial tachycardia following biatrial surgical ablation of atrial fibrillation in relation to the surgical lesion sets. Heart Rhythm. 2016;13 (5):1059-65.
13. Allessie M A, Bonke F I, Schopman F J. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ. Res. 1977;41 (1):9-18.
14. Brundel Bianca J J M, Ausma Jannie, van Gelder Isabelle C, Van der Want Johan J L, van Gilst Wiek H, Crijns Harry J G M, Henning Robert H. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc. Res. 2002;54 (2):380-9.
15. Thijssen V L, Ausma J, Borgers M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc. Res. 2001;52 (1):14-24.
16. Brundel Bianca J J M, Ke Lei, Dijkhuis Anne-Jan, Qi Xiao Yan, Shiroshita- Takeshita Akiko, Nattel Stanley, Henning Robert H, Kampinga Harm H. Heat shock proteins as molecular targets for intervention in atrial fibrillation. Cardiovasc. Res. 2008;78 (3):422-8.
17. S Kostin, GKlein, ZSzalay, SHein, EPBauer, JSchaper. Sructural correlate of atrial fibrillation in human patients. Cardiovasc Res. 2002; 54:361-379. View Article: Google Scholar. 2015;0:0-0.
18. Everett Thomas H, Wilson Emily E, Verheule Sander, Guerra Jose M, Foreman Scott, Olgin Jeffrey E. Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. Am. J. Physiol. Heart Circ. Physiol. 2006;291 (6):H2911-23.
19. ES Zado. EP news: allied professionals. Heart Rhythm. 2016. 2016;13:0-0.
20. Goldberger Jeffrey J, Arora Rishi, Green David, Greenland Philip, Lee Daniel C, Lloyd-Jones Donald M, Markl Michael, Ng Jason, Shah Sanjiv J. Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate. Circulation. 2015;132 (4):278-91.
21. Lee Ken W, Everett Thomas H, Rahmutula Dulkon, Guerra Jose M, Wilson Emily, Ding Chunhua, Olgin Jeffrey E. Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation. 2006;114 (16):1703-12.
22. Shi Yanfen, Li Danshi, Tardif Jean-Claude, Nattel Stanley. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc. Res. 2002;54 (2):456-61.
23. AJ Camm, PKirchhof, GYLip, USchotten, ISavelieva, SErnst. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010. 2010;0:0-0.
24. Magnani Jared W, Rienstra Michiel, Lin Honghuang, Sinner Moritz F, Lubitz Steven A, Mc Manus David D, Dupuis Josée, Ellinor Patrick T, Benjamin Emelia J. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation. 2011;124 (18):1982-93.
25. Schnabel Renate B, Sullivan Lisa M, Levy Daniel, Pencina Michael J, Massaro Joseph M, D'Agostino Ralph B, Newton-Cheh Christopher, Yamamoto Jennifer F, Magnani Jared W, Tadros Thomas M, Kannel William B, Wang Thomas J, Ellinor Patrick T, Wolf Philip A, Vasan Ramachandran S, Benjamin Emelia J. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373 (9665):739-45.
26. Youn Ji-Youn, Zhang Jun, Zhang Yixuan, Chen Houzao, Liu Depei, Ping Peipei, Weiss James N, Cai Hua. Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J. Mol. Cell. Cardiol. 2013;62 ():72-9.
27. Joseph Leroy C, Subramanyam Prakash, Radlicz Christopher, Trent Chad M, Iyer Vivek, Colecraft Henry M, Morrow John P. Mitochondrial oxidative stress during cardiac lipid overload causes intracellular calcium leak and arrhythmia. Heart Rhythm. 2016;13 (8):1699-706.
28. W-H Lim, E-KChoi, S-HKang, S-RLee, K-DHan. Underweight is a risk factor for atrial fibrillation: a nationwide population-based study (Abstr.). Heart Rhythm. 2016. 2016;13:0-0.
29. Kottkamp Hans. Atrial fibrillation substrate: the "unknown species"- from lone atrial fibrillation to fibrotic atrial cardiomyopathy. Heart Rhythm. 2012;9 (4):481-2.
30. V Fruster, LERyden, DSCannom. ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American heart Association Task Force on Practice Guidelines. Circulation. 2011. 2011;57:101-198.
31. Chatap Guy, Giraud Karine, Vincent Jean-Pierre. Atrial fibrillation in the elderly: facts and management. Drugs Aging. 2002;19 (11):819-46.
32. Houck Charlotte A, Teuwen Christophe P, Bogers Ad J J C, de Groot Natasja M S. Atrial tachyarrhythmias after atrial switch operation for transposition of the great arteries: Treating old surgery with new catheters. Heart Rhythm. 2016;13 (8):1731-8.
33. Sokal Adam, Lenarczyk Radoslaw, Kowalski Oskar, Mitrega Katarzyna, Pluta Slawomir, Stabryla-Deska Joanna, Streb Witold, Urbanik Zofia, Krzeminski Tadeusz F, Kalarus Zbigniew. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population. Heart Rhythm. 2016;13 (5):1088-95.
34. de Groot Natasja M S, Zeppenfeld Katja, Wijffels Maurits C, Chan Wing King, Blom Nico A, Van der Wall Ernst E, Schalij Martin J. Ablation of focal atrial arrhythmia in patients with congenital heart defects after surgery: role of circumscribed areas with heterogeneous conduction. Heart Rhythm. 2006;3 (5):526-35.
35. Veronica Guarner, Esther Rubio-Ruiz Maria. Aging, metabolic syndrome and the heart. Aging Dis. 2012;3 (3):269-79.
36. Wessely Rainer. Atherosclerosis and cell cycle: put the brakes on! Critical role for cyclin-dependent kinase inhibitors. J. Am. Coll. Cardiol. 2010;55 (20):2269-71.
37. Nikitin N P, Witte K K A, Thackray S D R, Goodge L J, Clark A L, Cleland J G F. Effect of age and sex on left atrial morphology and function. Eur J Echocardiogr. 2003;4 (1):36-42.
38. Takemoto Yoshio, Ramirez Rafael J, Yokokawa Miki, Kaur Kuljeet, Ponce- Balbuena Daniela, Sinno Mohamad C, Willis B Cicero, Ghanbari Hamid, Ennis Steven R, Guerrero-Serna Guadalupe, Henzi Bettina C, Latchamsetty Rakesh, Ramos-Mondragon Roberto, Musa Hassan, Martins Raphael P, Pandit Sandeep V, Noujaim Sami F, Crawford Thomas, Jongnarangsin Krit, Pelosi Frank, Bogun Frank, Chugh Aman, Berenfeld Omer, Morady Fred, Oral Hakan, Jalife José. Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes. JACC Basic Transl Sci. 2016;1 (3):143-154.
39. Wijffels M C, Kirchhof C J, Dorland R, Allessie M A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92 (7):1954-68.
40. Miyazaki Shinsuke, Nakamura Hiroaki, Taniguchi Hiroshi, Hachiya Hitoshi, Ichihara Noboru, Takagi Takamitsu, Iwasawa Jin, Kuroi Akio, Watanabe Tomonori, Hirao Kenzo, Iesaka Yoshito. Impact of the order of the targeted pulmonary vein on the vagal response during second-generation cryoballoon ablation. Heart Rhythm. 2016;13 (5):1010-7.
41. Yuan B X, Ardell J L, Hopkins D A, Losier A M, Armour J A. Gross and microscopic anatomy of the canine intrinsic cardiac nervous system. Anat. Rec. 1994;239 (1):75-87.
42. Scherlag Benjamin J, Nakagawa Hiroshi, Jackman Warren M, Yamanashi William S, Patterson Eugene, Po Sunny, Lazzara Ralph. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol. 2005;13 Suppl 1 ():37-42.
43. Po Sunny S, Nakagawa Hiroshi, Jackman Warren M. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 2009;20 (10):1186-9.
44. Potential clinical relevance of the "little brain" on the mammalian heart. Exp Physiol. 2008. 2008;93:165-176.
45. Identification of left atrial ganglionated plexi by dense epicardial mapping as ablation targets for the treatment of concomitanat atrial fibrillation. Pacing Clin Electrophysiol. 2013. 2013;36:1336-1341.
46. Ganglionated plexi and ligament of Marshall ablation reduces atrial vulnerability and causes stellate ganglion remodeling in ambulatory dogs (Abstr.). Heart Rhythm. 2016. 2016;13:2083-2060.
47. Shen Mark J, Choi Eue-Keun, Tan Alex Y, Lin Shien-Fong, Fishbein Michael C, Chen Lan S, Chen Peng-Sheng. Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol. 2011;9 (1):30-9.
48. Hou Yinglong, Scherlag Benjamin J, Lin Jiaxiong, Zhou Jing, Song Jianguo, Zhang Ying, Patterson Eugene, Lazzara Ralph, Jackman Warren M, Po Sunny S. Interactive atrial neural network: Determining the connections between ganglionated plexi. Heart Rhythm. 2007;4 (1):56-63.
49. Lin Jiaxiong, Scherlag Benjamin J, Niu Guodong, Lu Zhibing, Patterson Eugene, Liu Shaowen, Lazzara Ralph, Jackman Warren M, Po Sunny S. Autonomic elements within the ligament of Marshall and inferior left ganglionated plexus mediate functions of the atrial neural network. J. Cardiovasc. Electrophysiol. 2009;20 (3):318-24.
50. Evidence for increased atrial sympathetic innervations in persistent human atrial fibrillation. Pacing Clin Electrophysiol. 2006. 2006;0:821-829.
51. Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation. Implications for therapies targeting the atrial autonomous nervous system. Circ Arrhythm Electrophysiol. 2012. 2012;0:850-859.
52. Vagal denervation and atrial fibrillation inducibility : epicardial fat pad ablation does not have long-term effects. Heart Rhythm. 2006. 2006;0:701-708.
53. Mao Jun, Yin Xiandong, Zhang Ying, Yan Qian, Dong Jianzeng, Ma Changsheng, Liu Xingpeng. Ablation of epicardial ganglionated plexi increases atrial vulnerability to arrhythmias in dogs. Circ Arrhythm Electrophysiol. 2014;7 (4):711-7.
54. Is the atrial neural plexis a therapeutic target in atrial fibrillation?. Methodist Debakey Cardiovasc J. 2015. 2015;0:82-86.
55. Xi Yutao, Cheng Jie. Dysfunction of the autonomic nervous system in atrial fibrillation. J Thorac Dis. 2015;7 (2):193-8.
56. Nerve sprouting, sympathetic hyperinnervation and increased vulnerability of atrial fibrillation in a porcine model of metabolic syndrome (Abstr.). Heart Rhythm. 2016. 2016;13:54-0.
57. Peri-atrial fat is not predictive of outcome in hybrid atrial fibrillation (Abstr.). Heart Rhythm. 2016. 2016;13:303-0.
58. Prevention and regressive effect of weight loss and risk factor modification on atrial fibrillation (Reverse-AF) (Abstr.). Heart Rhythm. 2016. 2016;13:49-0.
59. Van Gelder I C, Smit M D, Alings M, Crijns H J G M. Upstream therapy in patients with early atrial fibrillation: The relevance of the Routine versus Aggressive upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) study. Neth Heart J. 2010;18 (11):522-3.
60. Qi Wen-Wei, Liu Tong, Xu Gang, Li Li-Feng, Liang Ying-Zi, Ye Lan, Li Guang- Ping. Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial. Trials. 2015;16 ():-.